Exosens (EPA:EXENS)
France
· Delayed Price · Currency is EUR | Market Cap | 3.16B |
| Revenue (ttm) | 468.20M |
| Net Income (ttm) | 42.70M |
| Shares Out | 50.76M |
| EPS (ttm) | n/a |
| PE Ratio | 74.06 |
| Forward PE | 33.18 |
| Dividend | 0.30 (0.48%) |
| Ex-Dividend Date | n/a |
| Volume | 243,374 |
| Average Volume | 108,760 |
| Open | 62.40 |
| Previous Close | 62.40 |
| Day's Range | 60.80 - 62.80 |
| 52-Week Range | 24.46 - 62.80 |
| Beta | n/a |
| RSI | 63.23 |
| Earnings Date | Feb 23, 2026 |
About Exosens
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultraviolet, short, medium, and long wave infrared, visible - near infrared, and mid-wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensif... [Read more]
Financial Performance
In 2025, Exosens's revenue was 468.20 million, an increase of 18.81% compared to the previous year's 394.08 million. Earnings were 42.70 million, an increase of 67.25%.
Financial StatementsNews
THEON completes the acquisition of a circa 9.8% stake in Exosens
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 7 January 2026 – Theon International Plc (THEON) is pleased to announce the completion of the acquisition of a circa 9.8% stake in Exosens SA (E...
Exosens lifts capacity plans as defense demand drives 23% revenue gain
Theon International To Acquire 9.8% Stake In Exosens For EUR 268.7 Mln
(RTTNews) - Theon International Plc announced that it has signed a definitive agreement with HLD Europe SCA, Invest Prince Henri SCA, and Invest Gamma Sarl—investment entities affiliated with Groupe H...
Exosens reaffirms 2024 outlook as NATO demand lifts sales
Exosens reaffirms 2024 outlook as NATO demand lifts sales
Exosens: Spectral And Imaging Opportunity With Attractive End Markets
Exosens, a leader in defense and industrial markets, had 35% revenue growth in 2024. It has 22% stock upside and growth-driven potential. Click to read more on EXOSF.